Patients with heart failure have a high risk of sudden death because the calcium inside their heart cells is not properly controlled.
New findings published in PLoS ONE, which reveal mechanisms that underlie this life-threatening risk, provide new possibilities for fighting it.
The study, led by researchers from the University of Bristol's School of Physiology and Pharmacology, show how two individual but very similar proteins cooperatively adjust the amount of calcium inside the heart cells, and how this dual regulation may degenerate in heart failure.
By removing individual RyR channels from heart cells and incorporating them into artificial membranes, the researchers were able to measure the tiny calcium currents that flow through a single channel molecule.
The team discovered that two individual proteins, called FKBP12 and FKBP12.6, bind tightly to the RyR channels and alter the amount of calcium that flows through them.
Their study shows that although FKBP12 and FKBP12.6 are almost identical, the proteins have very different functions. FKBP12 increases calcium fluxes through RyR channels while FKBP12.6 blocks the effects of FKBP12. It seems that this dual regulation by the two proteins may be damaged in heart failure.
Dr Rebecca Sitsapesan at the University, said: "Diseases of the heart and circulatory systems are the main cause of death in the UK and account for almost 191,000 deaths each year one in three deaths1. These new findings are important because we can use this information to help develop new treatments for patients with heart disease to reduce the risks of sudden cardiac death."